1 completed, 1 terminated. 2 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 2 | Completed 1, Terminated 1 |
Follow Placebo: new trials by email Literature Review of Placebo trials Research Report on Placebo
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Understanding How Opioids Affect the Experiential and Neural Signatures of Social Experiences Naltrexone Hydrochloride, Placebo - Naltrexone, Placebo | Early Phase 1 | Completed | San Diego State University | 217 | 2021-11-16 | 2026-09-10 |
| Pexacerfont for Stress-induced Food Craving Pexacerfont - Daily Oral Pexacerfont for 28 Days (300 mg/Day Loading Dose for 7 Days, Followed, Placebo | Early Phase 1 | Terminated | National Institute on Drug Abuse (NIDA) | 31 | 2012-06-01 | 2016-08-18 |
Feeding Behavior (1)
Behavior (1) · Behavior, Animal (1)
Naltrexone (1) · Sugars (1) · pexacerfont (1)
National Institute on Drug Abuse (NIDA) (1) · San Diego State University (1)
United States (2)
David H Epstein, Ph.D. (1) · Tristen Inagaki, PhD (1)
R01DA052883 (1)